In another study, Bagalagel et al. [24] evaluated the potential therapeutic effects of cycloastragenol in experimentally induced ulcerative colitis rats and examined the modulation of sphingosine kinase (SphK), macrophage inflammatory protein (MIP)-1α, and miR-143. This evidence concerns the gene CCL3 and ulcerative colitis.